51³Ô¹ÏÍø
Tag - merck
Subscribe
Digital
Print
July 25, 2026
Subscribe
Digital
Print
Heat
Parliament
China
Latest News
Home Delivery
51³Ô¹ÏÍø
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
MERCK
BUSINESS
Oct 20, 2023
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
Daiichi Sankyo is aiming for at least ?900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
WORLD
/
Science & Health
Jun 6, 2023
Cancer vaccines poised to unlock ¡®new treatment paradigm¡¯ with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
WORLD
/
Science & Health
Apr 17, 2023
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer¡¯s return.
COMMENTARY
/
World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma ¡ª but fighting tumors is vastly more complex than tackling COVID-19.
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia¡¯s invasion of Ukraine and the needs of sick patients.
WORLD
/
Science & Health
Feb 1, 2022
How does Merck¡¯s COVID-19 pill compare to Pfizer¡¯s?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
WORLD
/
Science & Health
Dec 24, 2021
Merck¡¯s COVID-19 pill comes with warning for pregnant women
U.S. regulators cleared the drug for emergency use Thursday but said it is not recommended for use in pregnant people.
BUSINESS
Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
WORLD
Nov 27, 2021
Merck says its antiviral pill is less effective in final analysis
A final analysis of a clinical trial said the antiviral pill reduced the risk of hospitalization and death among high-risk COVID patients by 30%, down from an earlier estimate of 50%.
51³Ô¹ÏÍø
/
Science & Health
Nov 10, 2021
Japan to pay $1.2 billion for 1.6 million courses of Merck¡¯s COVID-19 pill
Countries have rushed to sign deals to buy molnupiravir since data last month showed that when given early in the illness the drug could halve the chances of dying or being hospitalized.
51³Ô¹ÏÍø
/
Explainer
Oct 20, 2021
Oral drug molnupiravir seen as ¡®trump card¡¯ in Japan¡¯s battle against COVID-19
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.
WORLD
Oct 14, 2021
Rush to buy Merck¡¯s COVID-19 pill risks leaving poor countries behind
Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.
WORLD
/
Science & Health
Oct 2, 2021
Merck pill seen as ¡®huge advance,¡¯ raises hope of preventing COVID-19 deaths
An experimental antiviral pill developed by Merck & Co. could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19.
BUSINESS
/
FOCUS
Jun 4, 2021
Chinese drugmakers take aim at lucrative U.S. anti-cancer market
In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.
WORLD
/
Science & Health
Jul 23, 2019
Congo health minister¡¯s resignation over Ebola snub could unblock new vaccine
Congo¡¯s health minister resigned on Monday after being stripped of responsibility for managing the country¡¯s Ebola outbreak, potentially paving the way for the introduction of a second vaccine to contain the spreading epidemic.
WORLD
/
Science & Health
Aug 6, 2018
Experimental Ebola vaccinations to begin Wednesday in eastern Congo
Vaccinations against a new outbreak of Ebola virus in eastern Democratic Republic of Congo are due to begin on Wednesday, a senior official at the health ministry said on Sunday.
BUSINESS
Aug 15, 2017
Merck CEO quits Trump manufacturing council over Charlottesville, draws snide tweet revenge
Merck & Co. Inc. Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump¡¯s American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism.
WHAT¡¯S TRENDING
Editors' Picks
Japan weighs regulating Pokemon cards amid trading mania
Head of Swiss euthanasia firm dies after collapsing while ascending Mount Fuji
Indian brothers make manga debut in Japan
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
A perfect storm: Kaze Fujii fans flock to Fuji Rock
The sci-fi sensibilities of electronic trio Black Boboi
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
The 180-day locals: Life on Japan¡¯s digital nomad visa
Japan reveals hint of new defense spending target in fiscal blueprint
Podcast
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯
Longform
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By
Alex K.T. Martin
SUSTAINABLE 51³Ô¹ÏÍø
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER